Notable Runner: It Seems The Advisory Board Company Will Go Down. Have Another Big Decline

Notable Runner: It Seems The Advisory Board Company Will Go Down. Have Another Big Decline

The stock of The Advisory Board Company (NASDAQ:ABCO) is a huge mover today! The stock decreased 2.77% or $1.24 during the last trading session, hitting $43.5. About 208,460 shares traded hands. The Advisory Board Company (NASDAQ:ABCO) has risen 45.88% since March 1, 2016 and is uptrending. It has outperformed by 33.66% the S&P500.
The move comes after 5 months negative chart setup for the $1.79B company. It was reported on Oct, 4 by Barchart.com. We have $40.89 PT which if reached, will make NASDAQ:ABCO worth $107.40M less.

Analysts await The Advisory Board Company (NASDAQ:ABCO) to report earnings on November, 3. They expect $0.27 earnings per share, up 12.50% or $0.03 from last year’s $0.24 per share. ABCO’s profit will be $11.11M for 40.28 P/E if the $0.27 EPS becomes a reality. After $0.35 actual earnings per share reported by The Advisory Board Company for the previous quarter, Wall Street now forecasts -22.86% negative EPS growth.

The Advisory Board Company (NASDAQ:ABCO) Ratings Coverage

Out of 12 analysts covering Advisory Board (NASDAQ:ABCO), 9 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 75% are positive. Advisory Board has been the topic of 17 analyst reports since August 5, 2015 according to StockzIntelligence Inc. The rating was upgraded by Robert W. Baird to “Outperform” on Monday, August 17. The stock of The Advisory Board Company (NASDAQ:ABCO) has “Overweight” rating given on Friday, September 30 by Barclays Capital. Canaccord Genuity maintained it with “Buy” rating and $65 target price in Wednesday, August 5 report. Deutsche Bank upgraded it to “Buy” rating and $43 target price in Thursday, February 25 report. The stock of The Advisory Board Company (NASDAQ:ABCO) has “Strong-Buy” rating given on Friday, August 7 by Zacks. On Tuesday, November 10 the stock rating was initiated by Cantor Fitzgerald with “Buy”. Barclays Capital maintained The Advisory Board Company (NASDAQ:ABCO) on Wednesday, August 5 with “Overweight” rating. On Monday, October 12 the stock rating was upgraded by FBR Capital to “Outperform”. The firm earned “Market Perform” rating on Monday, August 31 by BMO Capital Markets. Raymond James downgraded the shares of ABCO in a report on Tuesday, July 19 to “Market Perform” rating.

According to Zacks Investment Research, “The Advisory Board Company provides best practices research and analysis to the health care industry, focusing on business strategy, operations and general management issues. The Company provides its best practices research and analysis through discrete annual programs to a membership of more than 2,000 hospitals, health systems, pharmaceutical and biotech companies, health care insurers, and medical device companies in the United States. Each program provides members with best practices research reports, executive education and other supporting research services.”

Insitutional Activity: The institutional sentiment decreased to 0.94 in Q2 2016. Its down 0.01, from 0.95 in 2016Q1. The ratio worsened, as 25 funds sold all The Advisory Board Company shares owned while 53 reduced positions. 28 funds bought stakes while 45 increased positions. They now own 39.77 million shares or 7.82% less from 43.15 million shares in 2016Q1.
Ensemble Capital Mgmt Ltd Liability Corporation holds 4.39% of its portfolio in The Advisory Board Company (NASDAQ:ABCO) for 427,720 shares. California State Teachers Retirement Sys holds 85,908 shares or 0.01% of its portfolio. Riverbridge Prns Llc reported 2.20M shares or 1.61% of all its holdings. Gotham Asset Mngmt Ltd Liability Corp holds 0.02% of its portfolio in The Advisory Board Company (NASDAQ:ABCO) for 46,974 shares. Moreover, Weatherbie Ltd Limited Liability Company has 1.8% invested in The Advisory Board Company (NASDAQ:ABCO) for 359,444 shares. Commercial Bank Of Montreal Can has 0.01% invested in the company for 245,976 shares. Moreover, Pacad Investment has 0.02% invested in The Advisory Board Company (NASDAQ:ABCO) for 4,000 shares. Marshall Wace Limited Liability Partnership accumulated 58,347 shares or 0.02% of the stock. Independent Port Consultants reported 2,720 shares or 0.03% of all its holdings. Atlanta Cap Management L L C, a Georgia-based fund reported 382,044 shares. The Texas-based Tpg Group (Sbs) Advsrs has invested 0.83% in The Advisory Board Company (NASDAQ:ABCO). Ftb holds 0% or 176 shares in its portfolio. Qs Invsts Ltd Liability holds 0% or 17 shares in its portfolio. Moreover, Mcf Advsrs Limited Liability has 0% invested in The Advisory Board Company (NASDAQ:ABCO) for 41 shares. Huntington Bank accumulated 0.01% or 4,988 shares.

Insider Transactions: Since April 14, 2016, the stock had 1 buy, and 8 insider sales for $729,356 net activity. $99,672 worth of shares were sold by Kirshbaum Michael T on Monday, August 22. Miller Cormac F sold 1,628 shares worth $51,526. The insider Musslewhite Robert W sold 5,500 shares worth $236,995. 2,736 shares were sold by ZUMWALT LEANNE M, worth $114,091. GRUA PETER J sold $103,600 worth of The Advisory Board Company (NASDAQ:ABCO) on Tuesday, August 16. On Tuesday, May 31 the insider KINDICK KELT bought $164,050. Farber Evan R sold $119,738 worth of stock.

More news for The Advisory Board Company (NASDAQ:ABCO) were recently published by: Prnewswire.com, which released: “The Advisory Board Company to Host Analyst and Investor Day September 26, 2016” on September 13, 2016. Prnewswire.com‘s article titled: “The Advisory Board Company Reports Results For Quarter Ended March 31, 2016” and published on May 05, 2016 is yet another important article.

ABCO Company Profile

The Advisory Board Company, incorporated on August 9, 2001, is a well-known provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value care and population health, revenue cycle performance, clinical activities and supply chain management. The Company’s education programs support colleges and universities in enrollment management; academic programming and student learning; faculty recruitment and retention; student advising and success; alumni affairs and advancement, and college and university operations. The Firm offers distinct membership programs, across four areas, which include best practices research and insight, performance technology software, consulting and management services, and data- and tech-enabled services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment